OAN’s Roy Francis
11:31 AM – Friday, May 26, 2023
Elon Musk’s brain-implant company, Neuralink, said that they have received approval from the United States Food and Drug Administration (FDA) for their first in-human clinical trial.
We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!
This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our…
